The work behind the name.
Stryker markets an ENT portfolio that includes balloon dilation, nasal implants, cryotherapy, navigation and surgical instruments. Its U.S. product pages cover technologies such as XprESS, LATERA and ClariFix. For practice leaders, the company is relevant to procedure adoption, equipment purchasing, physician education and the evolution of treatments delivered in office settings.
WHY FOLLOW
Its nasal and sinus portfolio spans office procedures and operating room technology.